Publications by authors named "Jennifer O Nwankwo"

The blood brain barrier's (BBB) unique endothelial cells and tight junctions selectively regulate passage of molecules to the central nervous system (CNS) to prevent pathogen entry and maintain neural homeostasis. Various neurological conditions and neurodegenerative diseases benefit from small molecules capable of BBB penetration (BBBP) to elicit a therapeutic effect. Predicting BBBP often involves assessment of molecular properties such as lipophilicity (log ) and polar surface area (PSA) using the CNS multiparameter optimization (MPO) method.

View Article and Find Full Text PDF

The NIH Virtual SARS-CoV-2 Antiviral Summit, held on 6 November 2020, was organized to provide an overview on the status and challenges in developing antiviral therapeutics for coronavirus disease 2019 (COVID-19), including combinations of antivirals. Scientific experts from the public and private sectors convened virtually during a live videocast to discuss severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) targets for drug discovery as well as the preclinical tools needed to develop and evaluate effective small-molecule antivirals. The goals of the Summit were to review the current state of the science, identify unmet research needs, share insights and lessons learned from treating other infectious diseases, identify opportunities for public-private partnerships, and assist the research community in designing and developing antiviral therapeutics.

View Article and Find Full Text PDF

One of the major contributors to sickle cell disease (SCD) pathobiology is the hemolysis of sickle red blood cells (RBCs), which release free hemoglobin and platelet agonists including adenosine 5'-diphosphate (ADP) into the plasma. While platelet activation/aggregation may promote tissue ischemia and pulmonary hypertension in SCD, modulation of sickle platelet dysfunction remains poorly understood. Calpain-1, a ubiquitous calcium-activated cysteine protease expressed in hematopoietic cells, mediates aggregation of platelets in healthy mice.

View Article and Find Full Text PDF
Article Synopsis
  • Dematin is an actin binding protein involved in the structure and stability of red blood cells, specifically at spectrin-actin junctions.
  • Researchers created a mouse model lacking the dematin gene, which resulted in severe anemia and significant changes in red blood cell shape and membrane stability.
  • Analysis revealed that while many proteins were normal, key proteins like spectrin and actin were decreased in these mutant cells, highlighting dematin's critical function in maintaining the membrane cytoskeleton's integrity.
View Article and Find Full Text PDF